Biopharmaceutical compositions comprising nucleic acids encoding IL-5 binding proteins
Abstract:
The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
Public/Granted literature
Information query
Patent Agency Ranking
0/0